KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,866,000 | +62.0% | 22,863 | +107.8% | 0.00% | 0.0% |
| Q2 2023 | $2,386,000 | +8.2% | 11,001 | -9.4% | 0.00% | 0.0% |
| Q1 2023 | $2,205,000 | -3.7% | 12,143 | +4.2% | 0.00% | 0.0% |
| Q4 2022 | $2,290,000 | +99.3% | 11,657 | +128.2% | 0.00% | – |
| Q3 2022 | $1,149,000 | +4003.6% | 5,109 | +2254.4% | 0.00% | – |
| Q2 2022 | $28,000 | -84.3% | 217 | -84.6% | 0.00% | – |
| Q1 2022 | $178,000 | -73.2% | 1,407 | -72.3% | 0.00% | – |
| Q4 2021 | $665,000 | +161.8% | 5,073 | +144.4% | 0.00% | – |
| Q3 2021 | $254,000 | -41.7% | 2,076 | -45.7% | 0.00% | – |
| Q2 2021 | $436,000 | +254.5% | 3,824 | +273.8% | 0.00% | – |
| Q1 2021 | $123,000 | +623.5% | 1,023 | +501.8% | 0.00% | – |
| Q4 2020 | $17,000 | +466.7% | 170 | +254.2% | 0.00% | – |
| Q1 2020 | $3,000 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |